Monographie - Dexrazoxane hydrochloride

Ultimo aggiornamento :
08/05/2024

Dexrazoxane hydrochloride

Struttura chimica

Nome commerciale

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Cardioxane	Austria, Brasile, Chile, Danimarca, Ecuador, Francia, Germania, Gran Bretagna, Irlanda, Italia, Messico, Perù, Polonia, Spagna, Ungheria, Venezuela
Cyrdanax	Francia, Germania
Dexrazoxane	Ecuador, Stati Uniti d’America
Dexrazoxano	Messico, Perù
Razox	Perù
Razoxane	Colombia
Rhianta	Messico
Savene	Belgio, Danimarca, Finlandia, Francia, Germania, Gran Bretagna, Grecia, Irlanda, Italia, Norvegia, Paesi Bassi, Polonia, Romania, Spagna, Svezia, Ungheria
Zinecard	Canada, Stati Uniti d’America
Zucordex	Messico

Bibliografia : Dexrazoxane hydrochloride

	Tipo	Pubblicazione
381	Rivista	Beijnen JH, Van Gijn R. Chemical stability of the cardioprotective agent ICRF-187 in infusion fluids. J Parenter Sci Technol 1993 ; 47: 166-171.
1423	Rivista	Trissel LA, Martinez JF, Gilbert DL. Compatibility of gemcitabine hyrochloride with 107 selected drugs during simulated Y-site injection. J Am Pharm Assoc 1999 ; 39: 514-518.
1754	Rivista	Trissel LA, Gilbert DL, Wolkin AC. Compatibility of docetaxel with selected drugs during simulated Y-site administration. Int J Pharm Compound 1999 ; 3: 241-244.
1949	Rivista	Tetef ML, Synold TW, Chow W, Leong L, Margolin K, Morgan R, Rashko J, Shibata S, Somlo G, Yen Y, Groshen S, Johnson K, Lenz HJ, Gandara D, Doroshow JH. Phase I trial of 96 hour continuous infusion of dexrazoxane in patients with advanced malignancies. Clinical Cancer Research 2001 ; 7: 1569-1576.
1953	Rivista	Trissel LA, Saenz CA, Ogundele AB, Ingram DS. Physical compatibility of pemetrexed disodium with other drugs during simulated Y-site administration. Am J Health-Syst Pharm 2004 ; 61: 2289-2293.
2201	Rivista	Kaiser J.D, Vigneron J, Zenier H, May I, Demor? B. Chemical and physical stability of dexrazoxane, diluted with Ringer's lactate solution, in polyvinyl and polyethylene containers. EJHP Science 2007 ; 13, 3: 55-59.
2224	Rivista	Romanazzi C, Sferra S, Campi A, Rabino B, Barbieri M, Castellani S, Sabbatini L, Scanavacca P. Dexrazoxane: Stabilià in soluzione. Bolletino SIFO 2007 ; 53: 178-180.
3581	Laboratorio	Dexrazoxane (Cardioxane®) - Résumé des caractéristiques du produit Clinigen Healthcare 2013
3611	Rivista	Zhang, Y.-P, Myers, A.L., Trinh, V.A, Kawedia, J.D, Kramer, M.A, Benjamin, R.S, Tran, H.T. Physical and chemical stability of reconstituted and diluted dexrazoxane infusion solutions. J Oncol Pharm Practice 2014 ; 20, 1: 58-64.

Mentions Légales